Martingale Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-15,260
| Closed | -$433K | – | 889 |
|
|
2023
Q1 | $433K | Buy |
15,260
+400
| +3% | +$11.3K | 0.01% | 646 |
|
|
2022
Q4 | $434K | Buy |
14,860
+104
| +0.7% | +$3.04K | 0.01% | 645 |
|
|
2022
Q3 | $391K | Buy |
14,756
+651
| +5% | +$17.3K | 0.01% | 666 |
|
|
2022
Q2 | $627K | Buy |
14,105
+100
| +0.7% | +$4.45K | 0.01% | 599 |
|
|
2022
Q1 | $694K | Buy |
14,005
+150
| +1% | +$7.43K | 0.01% | 568 |
|
|
2021
Q4 | $707K | Hold |
13,855
| – | – | 0.01% | 568 |
|
|
2021
Q3 | $773K | Buy |
13,855
+8,150
| +143% | +$455K | 0.01% | 570 |
|
|
2021
Q2 | $245K | Hold |
5,705
| – | – | ﹤0.01% | 762 |
|
|
2021
Q1 | $240K | Sell |
5,705
-200
| -3% | -$8.41K | ﹤0.01% | 787 |
|
|
2020
Q4 | $276K | Sell |
5,905
-26,400
| -82% | -$1.23M | ﹤0.01% | 761 |
|
|
2020
Q3 | $1.37M | Sell |
32,305
-26,499
| -45% | -$1.13M | 0.02% | 534 |
|
|
2020
Q2 | $2.82M | Buy |
58,804
+3,100
| +6% | +$149K | 0.03% | 437 |
|
|
2020
Q1 | $2.56M | Buy |
55,704
+19,900
| +56% | +$916K | 0.03% | 436 |
|
|
2019
Q4 | $2.15M | Buy |
35,804
+31,304
| +696% | +$1.88M | 0.02% | 580 |
|
|
2019
Q3 | $256K | Buy |
+4,500
| New | +$256K | ﹤0.01% | 953 |
|